Viewing Study NCT00058461

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:46 PM
Ignite Modification Date: 2026-02-21 @ 1:34 AM
Study NCT ID: NCT00058461
Status: TERMINATED
Last Update Posted: 2013-10-08
First Post: 2003-04-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-cell Childhood Acute Lymphoblastic Leukemia View
None Childhood Burkitt Lymphoma View
None Childhood Diffuse Large Cell Lymphoma View
None Childhood Immunoblastic Large Cell Lymphoma View
None L3 Childhood Acute Lymphoblastic Leukemia View
None Recurrent Childhood Acute Lymphoblastic Leukemia View
None Recurrent Childhood Large Cell Lymphoma View
None Recurrent Childhood Lymphoblastic Lymphoma View
None Recurrent Childhood Small Noncleaved Cell Lymphoma View
Keywords: